STOCK TITAN

Yatsen's $100 Million R&D Investment Wins Consumer Trust and Market Share

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Very Positive)
Tags

Yatsen (NYSE:YSG) highlighted that it has invested approximately $100 million (RMB 700 million) in R&D since 2020 as part of a broader industry shift toward technology-led beauty. The company cites a global strategy of three research centers, six joint labs and over 20 collaborations to support brand globalization and product efficacy.

Yatsen also noted Perfect Diary's international traction and a top-selling lipstick SKU recognition, positioning domestic Chinese brands as innovation-driven competitors abroad.

Loading...
Loading translation...

AI-generated analysis. Not financial advice.

Positive

  • $100 million R&D invested since 2020
  • Domestic brands 57% market share in 2024
  • Three global research centers (Shanghai, Guangzhou, Toulouse)
  • 6 joint research laboratories
  • 20+ collaborative research programs
  • Perfect Diary achieved top-selling lipstick SKU recognition

Negative

  • None.

News Market Reaction – YSG

+2.43%
1 alert
+2.43% News Effect

On the day this news was published, YSG gained 2.43%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

R&D investment: $100 million (RMB 700 million) China beauty share 2015: 43% China beauty share 2024: 57% +5 more
8 metrics
R&D investment $100 million (RMB 700 million) Accumulated since 2020
China beauty share 2015 43% Chinese beauty companies’ domestic market share in 2015
China beauty share 2024 57% Chinese beauty companies’ domestic market share in 2024
Domestic brands share nearly 60% Share of world’s second-largest beauty market held by Chinese brands
Global research centers 3 research centers Shanghai, Guangzhou and Toulouse
Joint research labs 6 laboratories Joint research labs in Yatsen’s innovation ecosystem
Collaborative programs more than 20 programs Collaborations with hospitals and universities
R&D team advanced degrees over half Share of R&D team with master’s or PhD degrees

Market Reality Check

Price: $2.66 Vol: Volume 61,541 vs 107,295 ...
low vol
$2.66 Last Close
Volume Volume 61,541 vs 107,295 20-day average (relative volume 0.57). low
Technical Trading below 200-day MA, with price $2.88 vs 200-day MA $6.00 and 75.11% below 52-week high.

Peers on Argus

YSG was down 1.37% with mixed peer moves: EPC -9.09%, NUS -1.08%, while HELE gai...

YSG was down 1.37% with mixed peer moves: EPC -9.09%, NUS -1.08%, while HELE gained 5.81% and SPB rose 1.73%. This pattern points to stock-specific rather than broad sector momentum.

Historical Context

5 past events · Latest: Apr 29 (Neutral)
Pattern 5 events
Date Event Sentiment Move Catalyst
Apr 29 Annual report filing Neutral +5.4% Form 20-F annual report filed, updating investors on 2025 performance and risks.
Mar 11 Convertible financing Positive +10.5% Private placement of RMB convertible notes and warrants totaling about US$120 million.
Mar 02 Q4 & FY 2025 earnings Positive -9.0% Strong revenue growth, higher gross margin, narrowed loss, and positive non-GAAP income.
Feb 23 Earnings date notice Neutral +1.2% Announcement of timing and access details for Q4 and full-year 2025 results call.
Nov 17 Q3 2025 earnings Positive -20.3% Q3 revenue and skincare growth with improved margins but shares dropped sharply afterward.
Pattern Detected

Positive fundamental or financing news has sometimes seen negative follow-through, with strong earnings in 2025 met by notable selloffs, while capital-raising and routine filings have aligned with positive price reactions.

Recent Company History

Over the past six months, Yatsen has reported strong growth, with Q3 and full-year 2025 earnings showing expanding revenues, higher gross margins, and narrowing losses. Despite this, shares fell 20.32% after Q3 results and 8.99% after Q4/FY 2025 earnings, suggesting a pattern of selling into good news. In contrast, the US$120 million convertible notes private placement and the 20-F filing saw positive price reactions, highlighting mixed sentiment around fundamentals versus financing and disclosure events.

Market Pulse Summary

This announcement highlights Yatsen’s roughly $100 million R&D commitment since 2020, a network of 3...
Analysis

This announcement highlights Yatsen’s roughly $100 million R&D commitment since 2020, a network of 3 research centers, 6 joint labs, and more than 20 collaborations, alongside rising domestic market share for Chinese beauty brands. In context with recent strong revenue and margin trends plus a US$120 million convertible financing, the focus is on technology-driven differentiation. Investors may watch how this innovation spend converts into sustained growth and profitability over time.

Key Terms

r&d, sku
2 terms
r&d financial
"approximately $100 million (RMB 700 million) in R&D investment since 2020"
Research and development (R&D) is the work a company does to discover new products, improve existing ones, or develop better ways of making things — like a kitchen testing recipes to create a hit dish. For investors it matters because R&D is where future sales and competitive advantages are born, but it also uses cash and carries risk, so R&D spending and outcomes signal a company’s growth potential and uncertainty.
sku technical
"recognized as the top-selling lipstick SKU by a Chinese brand worldwide"
A SKU (stock keeping unit) is a unique code a company assigns to a specific product variant—think of it as a product’s name tag that distinguishes size, color, model or packaging. Investors use SKUs to track which items sell, how fast inventory turns, and where profit comes from, so they reveal customer demand, supply-chain efficiency and revenue drivers much like each item in a supermarket tells the store which shelves are performing.

AI-generated analysis. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

SHANGHAI, May 7, 2026 /PRNewswire/ -- In a significant shift reshaping the global beauty industry, Chinese domestic cosmetics brands have captured nearly 60% of the world's second-largest beauty market. This shift is being driven by unprecedented investments in scientific innovation, as well as rapidly evolving consumer expectations. Yatsen Group, one of China's leading beauty companies, today highlighted how its approximately $100 million (RMB 700 million) in R&D investment since 2020 exemplifies the industry's transformation from price-based competition to technology-driven excellence.

Over the past decade, Chinese beauty companies have fundamentally strengthened their competitive position, with market share surging from 43% in 2015, according to Frost & Sullivan, to 57% in 2024, according to Xinhua News. This growth reflects a broader consumer evolution: Chinese beauty shoppers are increasingly prioritizing proven efficacy, scientific credibility, and innovation, a shift that domestic brands have actively capitalized on by ramping up investment in R&D and innovation to respond quickly to changing preferences.

As a result, Chinese cosmetics brands are moving away from reliance on cost competition toward building a long-term technological and brand advantage on the global stage.

Cheng Jing, Chief Scientific Officer of Yatsen Group, during an interview with CGTN (China Global Television Network)

"This growth is primarily driven by continuous advancements in innovation, brand equity, and product use experience," said Cheng Jing, Chief Scientific Officer of Yatsen Group. "Chinese consumers have become more sophisticated. Their focus has shifted from price to proven efficacy, safety, scientific credibility, and cultural identity."

Yatsen Global Innovation R&D Center

Importantly, this transformation extends far beyond marketing. Leading Chinese beauty companies are constructing world-class innovation ecosystems.

Yatsen's "1-3-4-6-20" global innovation strategy encompasses three research centers across Shanghai, Guangzhou, and Toulouse, France, with over half of its R&D team holding master's or PhD degrees. The company maintains six joint research laboratories and more than 20 collaborative programs with prestigious institutions including Saint-Louis Hospital in France, as well as Ruijin Hospital, Sun Yat-sen University and Fudan University in China.

"The industry is moving from supply-chain-driven 'product globalization' to innovation-led 'brand globalization,'" added Cheng Jing. "Looking ahead, our goal is to be a world-class beauty innovation pioneer, utilizing a resilient supply chain and 'Glocal' agility to meet the needs of sophisticated consumers worldwide."

This scientific infrastructure addresses what industry analysts identify as the new consumer mandate: products that deliver measurable results backed by rigorous research.

This focus is reflected in Yatsen's portfolio: Perfect Diary leads the emerging "makeup skinification" trend, DR.WU delivers clinic-grade skin renewal, Galénic focuses on cellular-level anti-aging science and Eve Lom leverages advanced neuroscience for emotional skincare benefits.

Global Ambitions, Local Insights

The domestic market success is proving to be a launchpad for international expansion. Since 2021, Yatsen's flagship brand Perfect Diary has gained traction in Southeast Asia and Japan. Its loose powder has consistently ranked among the top three in its category on major e-commerce platforms, according to data from Qoo10 Japan, Amazon Japan, Shopee Vietnam, and TikTok Vietnam—demonstrating that Chinese innovation can compete on performance.

According to one full year of continuous tracking data by Frost & Sullivan, Perfect Diary Biolip Essence Lipstick has been officially recognized as the top-selling lipstick SKU by a Chinese brand worldwide. This achievement stands as a significant milestone showcasing the global rise of technological innovation among Chinese brands.

According to CGTN, Chinese beauty companies are well positioned to benefit from the global shift toward a dual emphasis on efficacy and emotional value. With complete innovation capabilities spanning raw materials to finished products, and supply chain agility that enables rapid response to market trends, domestic brands have transformed former weaknesses into competitive advantages.

About Yatsen Group

Yatsen Holding Limited (NYSE: YSG) is a leading China-based beauty group with the vision of becoming a world-class pioneer in beauty innovation. Founded in 2016, the Company has launched and acquired numerous color cosmetics and skincare brands including Perfect Diary, Little Ondine, Pink Bear, Galénic, DR.WU (its mainland China business), and Eve Lom. Our brands are strategically positioned to capture a wide spectrum of consumer demographics and price points, ranging from the mass market to the prestige and clinical segments. Yatsen thrives on the synergy of brand equity, product strength and operational agility, anchored by a strong commitment to R&D and consumer insights.

Email: public.affairs@yatsenglobal.com
Website: www.yatsenglobal.com
LinkedIn: www.linkedin.com/company/yatsen

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/yatsens-100-million-rd-investment-wins-consumer-trust-and-market-share-302765259.html

SOURCE Yatsen Holding Limited

FAQ

How much has Yatsen (YSG) invested in R&D since 2020?

Yatsen has invested approximately $100 million (RMB 700 million) in R&D since 2020. According to the company, this funding supports three research centers, six joint labs and more than 20 collaborative research programs to boost product efficacy.

What is Yatsen's global innovation strategy described for YSG?

Yatsen's global innovation strategy is called "1-3-4-6-20", covering three research centers and multiple collaborations. According to the company, it combines global R&D sites, joint labs and partnerships to accelerate science-driven product development and brand globalization.

Has Perfect Diary (YSG) shown international sales traction?

Yes. Perfect Diary has gained traction in Southeast Asia and Japan, with its loose powder ranking top three on major e-commerce platforms. According to the company, platform data from Qoo10, Amazon Japan, Shopee Vietnam and TikTok Vietnam support this trend.

What evidence did Yatsen (YSG) cite for product efficacy recognition?

Yatsen cited Frost & Sullivan tracking naming Perfect Diary Biolip Essence Lipstick the top-selling lipstick SKU by a Chinese brand worldwide. According to the company, that recognition reflects consumer preference for efficacy-backed products.

How does Yatsen (YSG) position Chinese beauty brands globally?

Yatsen positions Chinese brands as shifting from price competition to innovation-led globalization. According to the company, stronger R&D, supply-chain agility and scientific credibility enable local brands to compete on performance internationally.